Navigation Links
Domain Registration Corp ("BioPharm Asia, Inc") Opens 360 New Drugstores in Jilin and Liaoning Provinces
Date:6/12/2009

SHENZHEN, China, June 12 /PRNewswire-Asia-FirstCall/ -- Domain Registration Corp. (OTC Bulletin Board: DOMR), today announces that the Company (in the process of changing its name to "BioPharm Asia Inc.") has opened 360 new drugstores in Jilin and Liaoning Provinces, through its subsidiary Tonghua Shengantang Medical & Pharmacy Company Limited. A majority of the 360 chain drugstores are strategically located in the following areas: Tonghua, Jilin, Changchun, Siping and Yanji in Jilin Province, as well as Dalian in Liaoning Province.

With the implementation of universal healthcare reforms and the continuous improvement of rural medical services in China, the second-tier and third-tier cities, towns and counties will begin receiving comprehensive medical coverage. Likewise, increases in disposable income throughout the rural population have accelerated the urbanization of these relatively more developed areas. At the same time, widespread chain store retailing is becoming more accepted in the rural markets, and "BioPharm Asia" is poised to take advantage of their increasingly dense population and purchasing power, especially in Jilin and Liaoning Provinces.

"The successful addition of 360 new drugstores constitutes a major step in improving BioPharm Asia's consumer reach and achieving distribution wide economies of scale," said Yunlu Yin, Chief Executive Officer. "By continuing to open new drugstores in target distribution markets like Jilin and Liaoning Provinces, BioPharm Asia is aggressively penetrating these pharmaceutical markets and appealing to China's rising middle class by catering directly to its rural medical needs."

About Domain Registration Corp ("BioPharm Asia, Inc.")

In the process of changing its corporate name to "BioPharm Asia, Inc.", the Company is primarily engaged in the retail sale of medical products in China, complemented by a series of integrated business segments that include the cultivation of Chinese herbal medicines, pharmaceutical production and wholesale medicine distribution. Following several successful acquisitions through China Northern Pharmacy Holding Group Limited, the Company has preliminarily completed the integration of its distribution channels, expanding its trading business (which includes chain stores, distribution and wholesale business) to include pharmaceutical manufacturing and cultivation of medicinal raw materials. For more information, please visit http://www.biopharmasiainc.com .

Forward-looking statement: Except for the historical information, the matters discussed in this news release may contain forward-looking statements, including, but not limited to, factors relating to future sales. These forward-looking statements may involve a number of risks and uncertainties. Actual results may differ materially based on a number of factors, including, but not limited to, uncertainties in product demand, risks related to doing business in China, the impact of competitive products and pricing, changing economic conditions around the world, release and sales of new products and other risk factors detailed in the company's most recent annual report and other filings with the Securities and Exchange Commission.

    For more information, please contact:

     Domain Registration Corp ("BioPharm Asia, Inc.")
     Lijun Zhang
     Tel:   +1-718-705-4217
     Email: vp@biopharmasiaco.com

'/>"/>
SOURCE Domain Registration Corp ("BioPharm Asia, Inc.")
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Domain walls that conduct electricity
2. NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
3. NorthPoint Domain and NYU Vascular Associates Partner to Develop New Generation of Care Delivery Informatics Instruments
4. Time Domain Showcases Precision Location Capability of Ultra Wideband PLUS Product Line at HIMSS 2008
5. Pasteuria Bioscience Receives EPA Registration for Nematode Control
6. Pharmacyclics Files Registration Statement for Rights Offering
7. Poniard Pharmaceuticals Files Shelf Registration
8. AMT Starts Preregistration Trial for Glybera(TM)
9. Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer
10. Advanced Life Sciences Announces Filing of Shelf Registration Statement
11. Intrasphere Technologies Releases Version 1.5 of Its PharmaCM Clinical Trial Registration Solution Powered by Microsoft
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... LEXINGTON, Massachusetts , February 4, 2016 - New ... --> - New FDA action date of July ... date of July 22, 2016   - ... the U.S. in the past decade indicated for the treatment of signs and ... Lifitegrast has the potential to be the only product approved in the ...
(Date:2/4/2016)... 4, 2016  CytoSorbents Corporation (NASDAQ: CTSO ... flagship CytoSorb® blood filter to treat deadly inflammation ... world, announced that CEO Dr. Phillip Chan ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... Conference Presentation Details: Where: Convene ...
(Date:2/4/2016)... Feb. 4, 2016 Sinovac Biotech Ltd. ("Sinovac" ... provider of biopharmaceutical products in China ... board of directors received on February 4, 2016 a ... a consortium comprised of PKU V-Ming ( Shanghai ... Ltd., CICC Qianhai Development ( Shenzhen ) ...
(Date:2/3/2016)... 2016  Discovery Laboratories, Inc. (NASDAQ: DSCO ... KL4 surfactant therapies for respiratory diseases, today announced ... inducement award as a component of employment compensation ... President and Chief Executive Officer.  The award was ... 1, 2016 and granted as an inducement material ...
Breaking Biology Technology:
(Date:2/3/2016)... , February 3, 2016 ... market research report "Automated Fingerprint Identification System Market by ... Search), Application (Banking & Finance, Government, Healthcare, and Transportation) ... MarketsandMarkets, the market is expected to be worth USD ... 21.0% between 2015 and 2020. The transformation and technology ...
(Date:2/2/2016)... 2016  BioMEMS devices deployed in hospitals ... medical screening and diagnostic applications, such as ... that facilitate and assure continuous monitoring without ... being bolstered through new opportunities offered by ... coupled with wireless connectivity and low power ...
(Date:2/2/2016)... YORK , Feb. 2, 2016 Technology Enhancements ... presents an analysis of the digital and computed radiography ... Malaysia , and Indonesia ... trends and market size, as well as regional market ... country and discusses market penetration and market attractiveness, both ...
Breaking Biology News(10 mins):